Beta Bionic, Inc (NASDAQ:BBNX) IPO will take place January, 30 on the NASDAQ exchange under the ticker BBNX.

The company is offering shares at an expected price between $16.00 and $17.00 per share with an insider lock-up period of 180 days ending on July 29, 2025.

See also: Benzinga IPO Calendar

About Beta Bionic, Inc

Beta Bionic, Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring PWD by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.